• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠滋养细胞肿瘤中肿瘤抑制基因p53无突变。

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.

作者信息

Shi Y F, Xie X, Zhao C L, Ye D F, Lu S M, Hor J J, Pao C C

机构信息

Women's Hospital, Zhejiang Medical University, Hangzhou, China.

出版信息

Br J Cancer. 1996 May;73(10):1216-9. doi: 10.1038/bjc.1996.233.

DOI:10.1038/bjc.1996.233
PMID:8630281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2074525/
Abstract

The objectives of this study were to better our understanding of the carcinogenesis of gestational trophoblastic tumours and to investigate the possible presence of mutational alteration of the p53 tumour-suppressor gene in these tumours. Amplification-based direct DNA sequencing was performed on 14 hydatidiform moles, six invasive moles, eight choriocarcinomas and ten normal early placental tissues. No mutation in exons 5-8 was detected in any of these 38 tissue specimens. These results suggest that a mutation in p53 tumour suppressor either does not exist or is a very rare event in gestational trophoblastic tumours. The gestational trophoblastic tumours probably involve a tumour-suppressor gene other than p53 gene or may follow a completely different pathway to their malignant phenotype.

摘要

本研究的目的是加深我们对妊娠滋养细胞肿瘤致癌作用的理解,并调查这些肿瘤中p53肿瘤抑制基因可能存在的突变改变。对14例葡萄胎、6例侵蚀性葡萄胎、8例绒毛膜癌和10例正常早期胎盘组织进行了基于扩增的直接DNA测序。在这38个组织标本中,未检测到外显子5-8的突变。这些结果表明,p53肿瘤抑制基因的突变在妊娠滋养细胞肿瘤中要么不存在,要么是非常罕见的事件。妊娠滋养细胞肿瘤可能涉及p53基因以外的肿瘤抑制基因,或者可能遵循完全不同的途径形成其恶性表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f0/2074525/f2621a6d757b/brjcancer00038-0062-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f0/2074525/1742e5e9fd2a/brjcancer00038-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f0/2074525/f2621a6d757b/brjcancer00038-0062-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f0/2074525/1742e5e9fd2a/brjcancer00038-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f0/2074525/f2621a6d757b/brjcancer00038-0062-b.jpg

相似文献

1
Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.妊娠滋养细胞肿瘤中肿瘤抑制基因p53无突变。
Br J Cancer. 1996 May;73(10):1216-9. doi: 10.1038/bjc.1996.233.
2
Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.人妊娠滋养细胞疾病中细胞增殖活性及P53抑癌基因的突变
West Indian Med J. 1993 Dec;42(4):142-3.
3
p53 expression in human gestational trophoblastic tumors.
Chin Med J (Engl). 1998 Apr;111(4):379-80.
4
Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia.妊娠滋养细胞肿瘤中肿瘤抑制基因p53的罕见突变
Carcinogenesis. 1994 Oct;15(10):2221-3. doi: 10.1093/carcin/15.10.2221.
5
The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.c-ras、c-erbB-2、nm23及p53基因产物的表达与滋养细胞肿瘤发生的关系及其对完全性葡萄胎恶变的预测意义
Gynecol Oncol. 2002 Jun;85(3):438-44. doi: 10.1006/gyno.2002.6652.
6
Current understandings of the molecular genetics of gestational trophoblastic diseases.妊娠滋养细胞疾病分子遗传学的当前认识
Placenta. 2002 Jan;23(1):20-31. doi: 10.1053/plac.2001.0744.
7
p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.妊娠滋养细胞肿瘤的p57(KIP2)免疫组化染色无法确定致病妊娠的类型。
Histopathology. 2004 Aug;45(2):135-41. doi: 10.1111/j.1365-2559.2004.01904.x.
8
Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.表皮生长因子及其受体在滋养层细胞恶性转化中的表达降低。
Cancer. 1993 Jun 15;71(12):4118-23. doi: 10.1002/1097-0142(19930615)71:12<4118::aid-cncr2820711251>3.0.co;2-h.
9
p53 expression in gestational trophoblastic disease.p53在妊娠滋养细胞疾病中的表达
Int J Gynecol Pathol. 1995 Apr;14(2):119-24. doi: 10.1097/00004347-199504000-00005.
10
[Detection of p53 gene mutations in human gestational trophoblastic neoplasia by polymerase chain reaction-single strand conformational polymorphism techniques].应用聚合酶链反应-单链构象多态性技术检测人妊娠滋养细胞肿瘤中的p53基因突变
Hunan Yi Ke Da Xue Xue Bao. 1997;22(4):338-40.

引用本文的文献

1
Gestational trophoblastic disease: understanding the molecular mechanisms of placental tumours.妊娠滋养细胞疾病:了解胎盘肿瘤的分子机制
Dis Model Mech. 2025 Jan 1;18(1). doi: 10.1242/dmm.052010. Epub 2025 Jan 28.
2
Transmission of a germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner.一名未受影响的男性携带者的生殖系突变传递给了他的孩子,导致小儿胶质母细胞瘤,同时也传递给了他的女性伴侣,导致妊娠性绒毛膜癌。
Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). doi: 10.1101/mcs.a002576. Print 2018 Apr.
3
Gestational choriocarcinoma associated with a germline TP53 mutation.

本文引用的文献

1
p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix.子宫颈炎性和肿瘤性疾病中的p53免疫反应性
J Pathol. 1993 Apr;169(4):425-30. doi: 10.1002/path.1711690407.
2
Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta.葡萄胎和正常人类胎盘中滋养层细胞中c-myc和c-fms癌基因的表达。
J Clin Pathol. 1993 Mar;46(3):204-7. doi: 10.1136/jcp.46.3.204.
3
Clinical implications of the p53 tumor-suppressor gene.p53肿瘤抑制基因的临床意义。
与种系TP53突变相关的妊娠性绒毛膜癌。
Fam Cancer. 2018 Jan;17(1):113-117. doi: 10.1007/s10689-017-9996-7.
4
Immunohistochemistry Study of and Expression in Trophoblastic Tissue and Their Predictive Values in Diagnosing Malignant Progression of Simple Molar Pregnancy.滋养层组织中[具体物质1]和[具体物质2]表达的免疫组织化学研究及其在诊断单纯性葡萄胎恶性进展中的预测价值
Iran J Cancer Prev. 2016 Jun 13;9(3):e4115. doi: 10.17795/ijcp-4115. eCollection 2016 Jun.
5
MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.微小 RNA-34a 通过调节 Delta 样蛋白 1 抑制绒癌的发生。
BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25.
6
Placental apoptosis in health and disease.胎盘凋亡与健康和疾病。
Am J Reprod Immunol. 2010 Sep;64(3):159-69. doi: 10.1111/j.1600-0897.2010.00837.x.
N Engl J Med. 1993 Oct 28;329(18):1318-27. doi: 10.1056/NEJM199310283291807.
4
Inhibition of in vitro enzymatic DNA amplification reaction by ultra-violet light irradiation.
Mol Cell Probes. 1993 Jun;7(3):217-9. doi: 10.1006/mcpr.1993.1031.
5
The p53 tumor suppressor gene frequently is altered in gynecologic cancers.p53肿瘤抑制基因在妇科癌症中经常发生改变。
Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):246-52. doi: 10.1016/s0002-9378(94)70414-7.
6
p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.B 细胞慢性淋巴细胞白血病中的 p53 基因突变与耐药性相关,且独立于 MDR1/MDR3 基因表达。
Blood. 1993 Dec 1;82(11):3452-9.
7
p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration.
J Pathol. 1993 Sep;171(1):27-34. doi: 10.1002/path.1711710107.
8
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.1993年沃尔特·休伯特讲座:p53肿瘤抑制基因在肿瘤发生中的作用。
Br J Cancer. 1994 Mar;69(3):409-16. doi: 10.1038/bjc.1994.76.
9
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.
Int J Cancer. 1993 Oct 21;55(4):562-5. doi: 10.1002/ijc.2910550407.
10
The lack of a role for p53 in astrocytomas in pediatric patients.p53在儿科患者星形细胞瘤中无作用。
Neurosurgery. 1994 Jun;34(6):967-72; discussion 972-3. doi: 10.1227/00006123-199406000-00003.